The U.S. cannabis industry has a new king. This new royalty is a product of a $2.1 billion merger, the largest buyout in the history of the young U.S. cannabis industry.
So which company has quickly jumped to the top of the sector?
Cannabis investors looking to buy low need to check out the biggest cannabis stock IPO of 2021.
An early industry leader valued at $1.7 billion just began trading on the Canadian Stock Exchange. And while this company is delivering crazy sales growth, shares have hardly moved since going public, making this a bargain opportunity in the cannabis sector.
Continue “$1.7 Billion Cannabis Stock IPO: Buy or Pass?”
For the last few years, the cannabis sector has experienced extended periods of strength followed by large pullbacks that lasted on average three to six months. During this period, buying cannabis stocks on a pullback has been a highly effective strategy.
Today, investors want to know if this a good time to buy cannabis stocks…
The short answer is yes.
I see five powerful catalysts that tell me this is a great time to buy cannabis stocks. Continue “5 Reasons It’s Time to Buy Cannabis Stocks”
Mergers and acquisitions (M&A) continue to heat up in the cannabis sector. This is a trend that investors need to know about because it’s creating an opportunity to pick up a quick gain.
The latest evidence?
Harvest Health and Recreation (CSE: HARV, OTC: HRVSF), one of the largest cannabis companies in the U.S., jumped 35% in five days after announcing it was being bought by Trulieve Cannabis (CSE: TRUL, OTC: TCNNF), also a cannabis giant in the U.S.
Shares of Harvest responded with a big rally. Shares jumped 35% in five days. Continue “Columbia Care (CSE: CHWF, OTC: CHWBF): The Next 35% Gain in 2 Days?”
The cannabis sector has a new king – an $8 billion, international juggernaut with more than a half-billion in revenue in the last 12 months.
I am going to reveal three key reasons why I call this early industry leader a long-term buy and hold. Continue “$8 Billion Weed Merger – Buy or Sell?”
Psychedelic stocks are quickly emerging as a red-hot sector.
Need evidence?
Take a look at Mind Medicine (NASDAQ: MNMD), a promising young biotech headquartered in New York, New York, that specializes in developing psychedelic drug therapies.
Shares were just uplisted from over-the-counter (OTC) markets to the NASDAQ stock exchange, and this stock is now up more than 1,000% in the last nine months. Continue “Psychedelic Stock IPO the Next 1,000% Gain?”
Easy To Follow Guidance To Capitalize On The Incredible Cannabis Industry